Podcast
ASX BRIEFS
Hosted by Andrew Musgrave · EN
Welcome to 'ASX BRIEFS,' the definitive podcast for enthusiasts, investors, and professionals keen on staying ahead of the curve in the Australian Stock Exchange (ASX). Hosted by Andrew Musgrave, 'ASX BRIEFS' delves deep into the heart of Australia's financial markets, bringing you insightful conversations with the minds shaping the future of investing down under. Each episode, join Andrew as he interviews a diverse lineup of fund managers, executives, and industry insiders, offering you a unique blend of expert analysis, strategic insights, and the latest trends affecting the ASX. Whether you're a seasoned investor or just starting out, 'ASX BRIEFS' is your go-to source for comprehensive updates and thought-provoking discussions designed to inform, inspire, and empower your investment journey. Tune in to 'ASX BRIEFS' and take the pulse of Australia's financial markets right at your fingertips.
17episodes
Episodes
Newest firstAll episodes
CLEANSPACE HOLDINGS LTD (CSX) - A Smarter PAPR For Real Work
Jun 2500:10:12Tap to summarizeSend us Fan MailSilica dust does not care about good intentions, and neither do regulators. We sit down with Gabrielle O’Carroll, CEO of Sydney-based CleanSpace Holdings Ltd, to unpack how respiratory protection is evolving as workplaces face tighter exposure limits, stronger enforcement, and rising expectations across mining, construction, quarrying and manufacturing.We start with the core problem: workers are exposed to hazardous airborne particles every day, yet traditional protection can be uncomfortable, awkward, and inconsistent in real-world use. Gabrielle explains why CleanSpace designs powered air purifying respirators (PAPR) that people actually want to wear, and how better comfort and fit can lift compliance and improve health outcomes over time. We also talk about the regulatory tailwinds in Australia, Europe and North America, including the impact of respirable crystalline silica limits and the public attention sparked by Australia’s engineered stone ban.Then we get specific on CleanSpace Agile, described as the world’s first loose fitting PAPR with patented AirSensit® technology that senses breathing demand and adjusts airflow in real time. We explore why the form factor matters, how ditching hoods, belts and hoses can change day-to-day usability, and why loose fitting protection helps employers manage fit testing burdens and clean-shaven policies. Finally, we dig into EN 12941 certification for Europe, the fast follow ANZ certification, the distribution ramp, the R&D roadmap, and what milestones may signal commercial traction into FY27.If you care about workplace safety tech, industrial PPE, or ASX-listed growth stories, listen now, then subscribe, share the episode with a mate, and leave a review so more people can find ASX Briefs.
Transcribe →INTELLIGENT MONITORING GROUP LTD (IMB) - How IMG Is Building A One-Stop Security Partner Across Australia And New Zealand
Jun 1700:17:11Tap to summarizeSend us Fan MailA security monitoring business doesn’t grow a $63.2m secured installation pipeline by accident, so we sat down with Dennison Hambling, Managing Director of Intelligent Monitoring Group (IMG), to understand what’s really driving the momentum. We talk candidly about why large enterprises across Australia and New Zealand are increasingly choosing a single national provider for electronic security, fire protection, and monitoring, and how IMG is rebuilding that “one trusted partner” position as the industry stays highly fragmented.We dig into the numbers behind the story, including operating cash flow and what Dennison calls improving earnings quality, plus the seasonality that can make quarter-to-quarter comparisons tricky. Dennison also shares how the company’s balance sheet journey and legacy tax losses influence capital allocation, and why he wants dividends to be sustainable when they arrive, not just symbolic.A big segment focuses on the completed acquisition of Blue Sky Hold Co, including Wormald New Zealand (Tyco NZ) and Red Wolf Security. We unpack what these businesses do, how they strengthen IMG’s New Zealand footprint to more than 500 people across 12 locations, and why national coverage matters when serving government and large multi-site customers. We also explore why prior alignment within the Johnson Controls ecosystem can reduce integration risk and simplify the transition.Then we zoom out to the technology shift: Video Guard and AI-powered video monitoring. Dennison explains how “threat assessment” changes the old alarm response model, why New Zealand is earlier in adoption than Australia, and how monitored video can expand the addressable market by competing with guarding and patrols while making real security more affordable.If you care about security industry trends, ASX growth stories, or the practical realities of scaling a services business across Australasia, hit play now. Subscribe, share the episode with a mate, and leave a review so more people can find the show.
Transcribe →AIRTASKER LTD (ART) - Inside Airtasker’s Q3 Growth And The New Membership Play
May 2600:10:35Tap to summarizeSend us Fan MailA marketplace can tell you more about the economy than a headline number, especially when thousands of everyday jobs are priced in real time. We sit down with Tim Fung to break down Airtasker’s Q3 performance and what’s really driving momentum in Australia: rising job volumes, strong completion rates, and an uplift in average task prices that reflects both demand and the cost-of-living squeeze pushing more people to earn on-platform. We also talk candidly about what’s next as consumer sentiment darkens and interest rate settings start to bite.From there, we zoom out to the brand battle. Airtasker’s focus is simple: when a roof leaks, a tap drips, or IKEA furniture needs assembling, we want Airtasker to be the first name people think of. We unpack the strategic media partnership with Nine Entertainment and how it complements other channels to lift unprompted brand awareness, while also using the balance sheet in a disciplined way through delayed settlement structures.Internationally, the story splits in two. The UK approaches a scale point where the marketplace can become cash generative quickly with low fixed costs, while the US remains in build mode, investing to strengthen network effects. We also cover the newer membership product, designed to lift frequency and create sticky recurring revenue through an annual fee and added credits. If you care about the gig economy, marketplace growth, ASX tech, and how pricing power shows up in the real world, this one is packed with signal. Subscribe, share it with a mate, and leave a review so more people can find the show.
Transcribe →MYECO LTD (MCO) - GRS Certified Recycling Meets The Supermarket Shelf
May 2400:16:11Tap to summarizeSend us Fan Mail“Recycled” sounds simple until you ask one awkward question: what exactly was recycled to make this product? We’re joined by Marie De Perthuis, CEO of MyEco Group Limited, to talk about how sustainable packaging earns trust when greenwashing is everywhere and shoppers are time-poor at the shelf.We get a clear view of MyEco Group’s model: a Melbourne-based brand with manufacturing and R&D capability that supports traceability from resin to finished goods. Marie explains why third-party certification (including GRS for post-consumer recycled materials) is more than a logo. It’s how retailers and consumers separate credible recycled content from vague claims, and how a category lifts its standards without asking shoppers to do forensic research.We also dive into growth drivers across two big channels. On the retail side, the new GRS certified post-consumer recycled bin liner range launching at Woolworths marks a major step beyond compostables and into a much larger market that directly competes with virgin plastic. On the council side, we unpack FOGO rollouts, tender wins, and why organics diversion, contamination reduction and landfill pressure are pushing councils to act sooner rather than later.If you care about sustainable packaging in Australia, compostable caddy liners, soft plastic recycling, or what “real” recycled content looks like at scale, this conversation delivers practical detail and a straightforward checklist for cutting through the noise. Subscribe, share the episode with a mate, and leave a review, then tell us: what do you look for before you trust a sustainability claim?
Transcribe →SYNTARA LTD (SNT) - How Syntara Builds A Biotech Pipeline With Multiple Shots On Goal
May 2200:14:54Tap to summarizeSend us Fan MailA small ASX biotech can feel impossible to value until the data starts landing, and that’s exactly where Syntara is headed. We’re joined by CEO Gary Phillips to map out a tight run of clinical catalysts and the thinking behind a pipeline built around extracellular matrix dysfunction and amine oxidase chemistry, backed by specialist institutional investors and real in-house drug discovery.We dig into Amsulostat, the lead program in myelofibrosis, and what positive FDA feedback actually means in practice: a clearer regulatory development pathway, a Phase 2B add-on design against placebo alongside JAK inhibitor standard of care, and stronger footing for potential partnering conversations in hematology and oncology. Gary also explains why safety and symptom score improvements matter so much at this stage, especially in diseases where current options can be hard to tolerate.From there we switch gears into two more high-interest areas. In myelodysplastic syndrome (MDS), we cover the unmet need, the significance of grant-backed trials in Germany and Australia, and why indication expansion can materially lift an asset’s commercial upside. We also explore SNT 4728 in isolated REM sleep behavior disorder (IRBD), a sleep condition that can precede Parkinson’s disease, and how a placebo-controlled study funded by Parkinson’s UK uses brain imaging to look for reduced inflammation. Finally, we talk skin scarring, including hypertrophic and keloid scars, why function and mental health outcomes matter, and what a once-daily topical approach could mean if results stack up.If you follow ASX biotech, clinical trials, FDA pathways, or early signals in Parkinson’s research, this chat is built for your watchlist. Subscribe, share the episode with a mate who tracks biotech's, and leave us a review so more people can find the show.
Transcribe →ORTHOCELL LTD (OCC) - How Remplir Makes Nerve Repair Simpler
May 2000:14:52Tap to summarizeSend us Fan MailA medical device can be brilliantly engineered and still fail for one simple reason: it never makes it from regulatory clearance to routine use in hospitals. We talk with Paul Anderson, CEO and Managing Director of Orthocell Limited, about how his team is trying to close that gap with a collagen-based regenerative medicine platform designed to support repair of bone, nerve and tendon injuries, and why their nerve product Remplir is now the commercial focus. We unpack the growth story behind recent revenue momentum, starting with a successful Australian launch where Remplir is widely used and reimbursed, then moving into the US where the opportunity is huge and the work is relentless. Paul explains the hybrid commercial model, how surgeon training really happens, and why adoption often comes in waves as clinicians build confidence case by case. We also get specific about the unglamorous but decisive step in US market access: Value Analysis Committee approvals, and how building a pipeline of VAC submissions can turn a hospital “yes” into real purchasing and repeat use. Clinical proof sits at the centre of everything. We discuss the importance of real-world evidence, what a strong post-market dataset signals to surgeons and payers, and how that evidence supports upcoming EU and UK regulatory submissions. The conversation also explores the defence channel, including approvals across US military medical centres and what real-world use in complex trauma settings can do for credibility. If you care about ASX healthcare growth, medical device commercialisation, nerve repair innovation, and the practical realities of scaling in the US, UK and Europe, this one is for you. Subscribe for more ASX Briefs conversations, share the episode with a mate, and leave a review with the one question you still have after listening.
Transcribe →RIMFIRE PACIFIC MINING (RIM) - Pioneering Critical Mineral Advancements: Rimfire Pacific Mining's David Hutton on Scandium Recovery and Strategic Expansion in New South Wales
Jun 14, 2024Tap to summarizeSend us Fan MailUnlock the secrets of critical minerals with our guest, David Hutton, Managing Director of Rimfire Pacific Mining. Discover how Rimfire is pioneering the exploration and recovery of scandium, cobalt, and copper in New South Wales. From the aerospace sector to clean energy advancements, scandium is revolutionizing industries, and Rimfire’s Murga Scandium Prospect is at the forefront. Tune in to learn about the impressive extraction rates and increased scandium grades that are setting new benchmarks in the field. David brings a wealth of knowledge on how securing a stable supply of scandium is vital for advanced technologies like solid oxide fuel cells.Additionally, we delve into Rimfire’s strategic future, including the release of maiden resources for the Murga and Melrose prospects. David sheds light on how Rimfire is rapidly expanding its scandium resource inventory and exploring promising cobalt and copper opportunities at Broken Hill. Listen as we highlight the technical prowess of Rimfire’s workforce, which is crucial in transforming the company from an explorer to a developer of high-value scandium resources. This episode is a must-listen for anyone interested in the future of critical minerals and their profound impact on technology.
Transcribe →